1. Department of Neurology, Sen. Paul D. Wellstone Muscular Dystrophy Specialized Research Center, University of Washington, Seattle, Washington, USA
2. Robb Consulting (contractor of REGENXBIO, Inc.), Columbia, Maryland, USA
3. AFMTelethon, Evry, France
4. Solid Biosciences, Inc., Charlestown, Massachusetts, USA
5. REGENXBIO, Inc., Rockville, Maryland, USA
6. Spark Therapeutics, Inc., Philadelphia, Pennsylvania, USA
7. University of California Davis Medical Center, Sacramento, California, USA
8. Hyman, Phelps & McNamara, P.C. (former contractor of REGENXBIO, Inc.), Washington, District of Columbia, USA
9. F. Hoffmann-La Roche, Ltd., Basel, Switzerland
10. Former contractor of REGENXBIO, Inc., Rockville, Maryland, USA; and
11. Department of Molecular Microbiology and Immunology, Neurology, Biomedical Sciences, and Biomedical, Biological & Chemical Engineering, University of Missouri, Columbia, Missouri, USA.